13F Holdings
中文EN

ENOV Enovis CORP

Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 1420800 · Fiscal year ends 12/31

Financial factors as of 2026-10-02 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY3.3%
TTM net income YoY61.4%
TTM EPS YoY62.1%
Revenue 3-yr CAGR11.6%
Net income 3-yr CAGR—

Margins

Gross margin61.3%
Operating margin-20.6%
Net margin-22.9%
FCF margin3.0%
EBITDA margin37.7%

Returns

ROE-30.0%
ROA-12.9%
ROIC (approx.)-12.3%
Asset turnover0.56x

Leverage & solvency

Liabilities / assets60.0%
Debt / equity0.84x
Current ratio2.15x
Interest coverage-14.69x

Cash quality & payout

Operating cash flow / net income-0.49x
Accruals ratio-19.3%
Payout ratio—
Capex / revenue8.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$2.25B$2.11B$1.71B$1.56B$1.43B
Cost of revenue$902.79M$926.87M$716.42M$693.72M$648.51M
Gross profit$1.35B$1.18B$990.78M$869.38M$777.67M
R&D expense$120.33M$91.30M$75.33M$60.83M$49.09M
SG&A expense$1.07B$1.03B$830.30M$772.91M$665.77M
Operating income-$1.12B-$775.72M-$65.71M-$71.18M-$62.80M
Interest expense$34.82M$57.10M$19.75M$24.05M$29.11M
Pretax income-$1.16B-$822.92M-$67.13M-$2.07M-$121.78M
Income tax$22.29M$4.49M-$13.29M$36.12M-$19.53M
Net income-$1.18B-$825.49M-$33.26M-$13.29M$71.66M
EBITDA$219.89M$152.11M$151.40M$131.79M$124.19M
EPS (basic)-20.75-14.93-0.61-0.251.40
EPS (diluted)-20.75-14.93-0.61-0.251.40
Weighted avg. shares (diluted)57.07M55.28M54.49M54.07M51.14M
Balance sheet
Cash & equivalents$36.39M$48.17M$36.19M$24.30M$680.25M
Receivables$442.79M$407.03M$291.48M$267.38M$254.96M
Inventory$584.38M$547.12M$468.83M$426.64M$356.23M
Current assets$1.21B$1.15B$896.52M$795.02M$2.30B
PP&E, net$507.06M$404.50M$270.80M$236.74M$235.11M
Goodwill$718.30M$1.69B$2.06B$1.98B$1.93B
Intangibles$1.24B$1.32B$1.13B$1.11B$1.15B
Total assets$3.83B$4.72B$4.51B$4.27B$8.52B
Current liabilities$598.47M$529.00M$369.61M$565.20M$1.02B
Short-term debt$35.00M$20.03M$0$219.28M$7.70M
Long-term debt$1.26B$1.31B$466.16M$40.00M$2.08B
Total debt$1.30B$1.33B$466.16M$259.28M$2.09B
Total liabilities$2.34B$2.15B$1.09B$823.45M$3.85B
Shareholders' equity$1.49B$2.56B$3.42B$3.45B$4.62B
Net debt$1.26B$1.28B$429.97M$234.98M$1.41B
Shares outstanding57.19M55.88M54.60M54.23M52.08M
Cash flow statement
Operating cash flow$217.29M$113.50M$134.99M-$55.86M$356.10M
Capital expenditure$197.38M$180.71M$122.22M$105.45M$104.24M
Free cash flow$19.92M-$67.21M$12.77M-$161.31M$251.86M
Investing cash flow-$179.37M-$955.47M-$242.47M-$176.39M-$320.48M
Financing cash flow-$52.40M$846.82M$127.80M-$465.13M$584.91M
Depreciation & amortization$1.34B$927.83M$217.11M$202.97M$186.99M
Stock-based compensation$32.92M$29.66M$34.06M$38.95M$35.35M
Share buybacks$3.50M$4.77M$0$0—

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.